Literature DB >> 491722

Reversal of ischemic damage with secondary blood cardioplegia.

H L Lazar, G D Buckberg, A J Manganaro, R P Foglia, H Becker, D G Mulder, J V Maloney.   

Abstract

After severe ischemic injury, it is usually necessary to prolong bypass to enhance recovery. This study tests the hypothesis that the best reversal of ischemic damage is achieved by briefly rearresting the postischemic heart with a continuous infusion of an oxygenated cardioplegic solution (secondary blood cardioplegia) during the period when bypass must be prolonged. Twenty dogs underwent 45 minutes of normothermic ischemic arrest. Fifteen minutes after unclamping, no heart could support the systemic circulation. In all dogs, oxygen demands were lowered by extending bypass for 30 minutes. In 10 of these dogs, demands were further lowered by rearresting the heart for 5 minutes with a continuous infusion of a 37 degrees C blood cardioplegic solution (K+28 mEq/L; pH 7.6; Ca++ 1 mEq/L) at a pressure of 50 mm Hg. Hearts treated with secondary blood cardioplegia showed greater recovery in the rate of contraction (-dP/dt 75% versus 62%, p less than 0.05) and relaxation (-dP/dt 76% versus 58%, p less than 0.05), better recovery of compliance (85% versus 51%, p less than 0.05), a higher stroke work index (0.72 versus 0.50 gm-m/Kg, p less than 0.05), and more ability to augment oxygen uptake (85% versus 45%, p less than 0.05) to meet the demands of the working heart than hearts treated by prolonging bypass alone. We conclude that rearresting the heart with a brief, continuous infusion of a blood cardioplegic solution results in more complete reversal of ischemic damage than possible by prolongation of a bypass alone. We believe that the increased recovery with secondary cardioplegia results from diversion of delivered oxygen toward reparative processes rather than its being expended needlessly on electromechanical work during the time when bypass must be prolonged.

Entities:  

Mesh:

Year:  1979        PMID: 491722

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  The effect of magnesium added to secondary cardioplegia on postischemic myocardial metabolism and contractile function--a 31P NMR spectroscopy and functional study in the isolated pig heart.

Authors:  G Tian; G P Biro; B Xiang; K W Butler; R Deslauriers
Journal:  Basic Res Cardiol       Date:  1992 Jul-Aug       Impact factor: 17.165

2.  Prevention of postischemic reperfusion injury: the improvement of myocardial tissue blood flow after ischemia by terminal nicorandil-Mg cardioplegia.

Authors:  H Orita; M Fukasawa; S Hirooka; T Minowa; H Uchino; M Washio
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Energy conserving chemical defibrillation of ventricular fibrillation: A randomized two phase controlled blinded trial.

Authors:  Keith A Marill; David D Salcido; Matthew L Sundermann; Allison C Koller; James J Menegazzi
Journal:  Resuscitation       Date:  2016-03-31       Impact factor: 5.262

4.  Effects of warm blood cardioplegic solution on myocardial protection.

Authors:  X L Du; H J Lan; Z Q Sun
Journal:  J Tongji Med Univ       Date:  1995

5.  Accelerated myocardial metabolic and functional recovery with terminal nicorandil-Mg cardioplegia in heart transplantation.

Authors:  H Orita; T Shimanuki; M Fukasawa; H Abe; S Kuraoka; S Hirooka; M Washio
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.